In the ob/ob mouse model of NAFLD, metformin enhances the activity of PRKA by activating SIRT1-FOXO signaling pathways, thereby inducing autophagy and facilitating lipid metabolism in NAFLD (143). This evidence concerns the gene SIRT1 and metabolic dysfunction-associated steatotic liver disease.